Insider trading · Q3 2026 · CIK 1533743

Processa Pharmaceuticals, Inc. (PCSA) insider trading.

In Q3 2026, insiders at Processa Pharmaceuticals, Inc. reported 6 non-derivative transactions on 16 Forms 3, 4 and 5: 5 open-market purchases worth $26K and 0 sales.

Transactions
6
Purchases (P)
5
Sales (S)
0
Net shares, P minus S
13,407
Insiders
5
Last filed
2026-08-11

Insiders

InsiderRelationshipTransactionsBuysSales
Ng George KDirector, Officer · Chief Executive Officer210
Young DavidDirector, Officer · Pres. Research & Development110
Skibsted RussellOfficer · Chief Financial Officer110
Lin PatrickOfficer · Chief Business - Strategy Off110
Guy WendyOfficer · Chief Administrative Officer110

Transactions

6 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-08Ng George KM (A)1,600—17,092Form 4
2026-07-01Ng George KP (A)3,057$1.9315,492Form 4
2026-06-30Young DavidP (A)2,531$1.9321,729Form 4
2026-06-30Skibsted RussellP (A)3,277$1.9316,689Form 4
2026-06-30Lin PatrickP (A)2,106$1.9313,113Form 4
2026-06-30Guy WendyP (A)2,436$1.9314,394Form 4

Transaction codes in this quarter

Get PCSA insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1533743&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · PCSA company page · Processa Pharmaceuticals, Inc. on SEC.gov

Questions

Are insiders buying or selling Processa Pharmaceuticals, Inc. (PCSA)?

In Q3 2026, insiders at Processa Pharmaceuticals, Inc. reported 6 non-derivative transactions on 16 Forms 3, 4 and 5: 5 open-market purchases worth $26K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Processa Pharmaceuticals, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/pcsa.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.